Insider Trading June 24, 2026 01:48 PM

VICR Director Andrew D’Amico Executes $248,820 Stock Sale Under Pre-Arranged Plan

Insider transaction coincides with strong Q1 2026 earnings and raised guidance, though shares trade at a premium valuation.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
VICR

VICOR CORP (NASDAQ:VICR) director Andrew D’Amico sold 754 shares on June 23, 2026, generating $248,820 through a Rule 10b5-1 trading plan. The transaction followed the exercise of non-qualified stock options for an equivalent number of shares. This activity occurs as VICR shares have surged 641% over the past year, trading near $319 on a $14.69 billion market cap, while the company reports strong Q1 2026 earnings and revised Q2 guidance upward.

VICR Director Andrew D’Amico Executes $248,820 Stock Sale Under Pre-Arranged Plan
VICR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • VICR director Andrew D’Amico sold 754 shares at $330.00 per share under a Rule 10b5-1 plan, netting $248,820, while simultaneously exercising options for 754 shares at $53.07 per share.
  • The company reported strong Q1 2026 financial results, with EPS of $0.44 beating estimates of $0.37, and revenue of $112.97 million exceeding forecasts by 3.59%.
  • Vicor raised its Q2 revenue guidance to $142 million, driven by higher product revenues and royalties from a new patent license agreement, while Needham raised its price target to $400.

Andrew D’Amico, a director at VICOR CORP (NASDAQ:VICR), executed a significant stock transaction on June 23, 2026. D’Amico sold 754 shares of common stock at a price of $330.00 per share, resulting in total proceeds of $248,820. The sale was conducted pursuant to a Rule 10b5-1 trading plan that D’Amico initially adopted on September 12, 2024.


On the same date, D’Amico acquired 754 shares of common stock through the exercise of non-qualified stock options. The exercise price for these options was $53.07 per share, totaling $40,014. These specific options are set to expire on June 23, 2033. Following the completion of these transactions, Andrew D’Amico directly holds 0 shares of VICOR CORP common stock.


The insider sale occurs against a backdrop of substantial price appreciation for VICR. The stock has surged 641% over the past year and currently trades at $318.81, reflecting a market capitalization of $14.69 billion. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value estimate. The company trades at a P/E ratio of 109.


Recent corporate developments highlight strong operational performance. Vicor Corporation reported strong first-quarter 2026 earnings, with earnings per share (EPS) of $0.44, surpassing the forecasted $0.37. The company’s revenue reached $112.97 million, exceeding expectations by 3.59%. Additionally, Vicor raised its second-quarter revenue guidance from $126 million to $142 million, attributing this increase to higher product revenues and royalties from a new patent license agreement.


An original equipment manufacturer has secured an all-inclusive license to Vicor’s patented power system technology, which includes Factorized Power and Vertical Power Delivery technologies. In related analyst coverage, Needham has raised its price target for Vicor to $400, citing the company’s updated long-term financial model, which now aims for revenue of $2.5 billion. Previously, Needham increased the target to $350 due to Vicor’s revised second-quarter revenue guidance.


At Vicor’s annual meeting, shareholders elected eleven directors and approved executive compensation. These developments reflect a period of significant activity and strategic advancements for Vicor Corporation. Real-time data indicates the stock traded at 321.68 with a change of -14.44 (-4.30%) at 14:04:38 USD.

Risks

  • VICR shares trade at a P/E ratio of 109, and InvestingPro analysis suggests the stock appears overvalued relative to its Fair Value estimate, indicating potential valuation pressure in the semiconductor and power electronics sectors.
  • The insider sale occurs after a 641% stock surge over the past year, and the director now holds zero shares, which may signal caution regarding near-term valuation levels in the broader technology market.

More from Insider Trading

Executive Capital Commitment at Bed Bath & Beyond Aug 6, 2026 EXLService President Vikas Bhalla Executes $384,890 Share Sale Under Pre-Existing Trading Plan Aug 6, 2026 Arcutis Biotherapeutics Executive Divests Shares Amid Strong Financial Backdrop Aug 6, 2026 Executive Capital Deployment and Leadership Restructuring at Hanover Bancorp Aug 3, 2026 Adaptive Biotechnologies Executive Liquidates Shares as Volume Metrics Diverge From Profitability Aug 3, 2026